Daily Sepsis Research Analysis
Three high-impact studies advanced sepsis care across the translational spectrum: a multicenter EClinicalMedicine study delivered and validated a real-time sepsis risk model for acute gastrointestinal bleeding; a prospective Sierra Leone cohort confirmed shock index thresholds to triage postpartum hemorrhage and maternal sepsis; and a JCI Insight mechanistic study identified IRF7 as a driver of macrophage autophagy, improving bacterial clearance and outcomes in murine sepsis.
Summary
Three high-impact studies advanced sepsis care across the translational spectrum: a multicenter EClinicalMedicine study delivered and validated a real-time sepsis risk model for acute gastrointestinal bleeding; a prospective Sierra Leone cohort confirmed shock index thresholds to triage postpartum hemorrhage and maternal sepsis; and a JCI Insight mechanistic study identified IRF7 as a driver of macrophage autophagy, improving bacterial clearance and outcomes in murine sepsis.
Research Themes
- Dynamic risk stratification and early warning for sepsis
- Low-resource triage tools for postpartum hemorrhage and maternal sepsis
- Host-directed therapy via autophagy in sepsis
Selected Articles
1. Real-time risk prediction model for sepsis in patients with acute gastrointestinal bleeding: development and multicenter validation of a dynamic monitoring tool.
In 1,449 AGIB patients, a multivariable logistic-regression nomogram predicted Sepsis-3 events and outperformed GBS, APACHE II, and SOFA across retrospective training, prospective internal, and external validation cohorts. Calibration, SHAP interpretability, and decision-curve analysis supported clinical utility, and a real-time EHR warning system was implemented.
Impact: This model bridges development-to-deployment with prospective and external validation and live clinical integration, enabling earlier recognition and preemptive management of sepsis in a high-risk AGIB population.
Clinical Implications: Incorporating the nomogram into EHRs can prioritize monitoring, timely cultures/source control, and early antibiotics for high-risk AGIB patients, potentially reducing sepsis incidence and mortality versus standard scores.
Key Findings
- Developed a logistic-regression nomogram predicting Sepsis-3 in AGIB with multicenter retrospective training and prospective internal/external validation (n=1,449).
- Model discrimination surpassed GBS, APACHE II, and SOFA; calibration and decision-curve analysis supported net clinical benefit.
- SHAP explained feature contributions, and a real-time clinical warning system was implemented for dynamic monitoring.
Methodological Strengths
- Multicenter design with prospective internal and external validation
- Transparent modeling with calibration, decision-curve analysis, and SHAP interpretability
Limitations
- Observational design with potential residual confounding and selection bias
- Generalizability beyond participating Chinese centers requires further validation
Future Directions: Test the model's transportability across diverse health systems and evaluate clinical impact via stepped-wedge or randomized implementation trials; explore adaptive updating with streaming data.
BACKGROUND: Patients with acute gastrointestinal bleeding (AGIB) carries a significant risk of sepsis, particularly in intensive care units. We aimed to develop a validated predictive model for sepsis risk stratification to guide clinical management. METHODS: This multicenter study (Jan, 2020-Jul, 2024) in China included 1449 patients with AGIB. Participants were enrolled into a retrospective training (n = 878) cohort, and prospective internal validation (n = 187; prospectively enrolled from lead center) and external validation (n =
2. Evaluating shock index for prediction of adverse maternal outcomes related to postpartum haemorrhage and maternal sepsis in Sierra Leone: a prospective observational cohort study.
Among 495 PPH and 855 sepsis cases, SI consistently outperformed other vital signs and MSI to predict adverse outcomes; risk rose across predefined SI bands, with SI ≥1.7 strongly associated with maternal death. Sensitivity reached 88–95% with high NPV, though hypertension attenuated performance.
Impact: This large, prospective LMIC study validates simple SI thresholds to triage PPH and sepsis, enabling immediate, scalable improvements in maternal care where resources are limited.
Clinical Implications: Adopt SI categories (<0.9; 0.9–1.69; ≥1.7) for rapid triage and escalation in maternity wards and emergency settings, while adjusting protocols for hypertensive patients where SI performance is reduced.
Key Findings
- Prospective cohort of 1,350 women (PPH n=495; sepsis n=855) showed SI consistently outperformed other vitals and MSI for adverse outcome prediction.
- Predefined SI thresholds demonstrated increasing risk, with SI ≥1.7 strongly associated with maternal death; sensitivity 88.4–95.2% and NPV 73.8–98.9%.
- SI performance for maternal death prediction was poorer with hypertension (AUC 0.59 vs 0.86; p=0.0020).
Methodological Strengths
- Prospective, multi-hospital cohort in a low-resource setting
- Validation of predefined SI thresholds with comprehensive predictive metrics
Limitations
- Observational design limits causal inference and residual confounding may persist
- Generalizability beyond Sierra Leone and protocol adaptation for hypertensive patients require further study
Future Directions: Implementation research to integrate SI-based triage into national guidelines, and trials testing SI-triggered care bundles; refine thresholds stratified by hypertension and comorbidities.
BACKGROUND: Postpartum haemorrhage (PPH) and sepsis account for more than half of global maternal deaths. Shock index (SI), the ratio of heart rate to systolic blood pressure, has shown superior prediction of adverse outcomes compared to other vital signs, but most studies are retrospective, with limited evidence in sepsis. We aimed to prospectively evaluate SI for adverse outcome prediction in PPH and sepsis. METHODS: This prospective cohort study was undertaken between March 2022 and July 2023 in thre
3. IRF7 drives macrophages to kill bacteria and improves septic outcomes via autophagy.
Loss of Irf7 increased mortality in polymicrobial sepsis, whereas IRF7 transcriptionally upregulated autophagy genes to promote autophagosome formation, autolysosome maturation, and bacterial killing in macrophages. AAV9-mediated Irf7 overexpression enhanced pathogen clearance and improved organ injury, nominating IRF7 as a host-directed therapeutic target.
Impact: This work identifies IRF7 as a central, druggable regulator of macrophage autophagy in sepsis, linking innate immune transcriptional control to enhanced bacterial clearance and improved outcomes.
Clinical Implications: Pharmacologic or gene-based augmentation of IRF7-autophagy pathways could complement antibiotics in sepsis, particularly in antimicrobial resistance or immunoparalysis; biomarkers of IRF7 activity might guide patient selection.
Key Findings
- Irf7 deficiency increased mortality in murine polymicrobial sepsis.
- IRF7 transcriptionally upregulated autophagy genes, enhancing autophagosome formation, autolysosome maturation, and macrophage bacterial killing.
- AAV9-Irf7–mediated overexpression improved pathogen clearance and reduced septic organ injury, operating independently of antibiotics.
Methodological Strengths
- Complementary loss- and gain-of-function approaches in vivo with mechanistic readouts
- Direct linkage of transcriptional regulation to functional autophagic killing in macrophages
Limitations
- Preclinical murine models may not fully capture human sepsis heterogeneity
- Gene therapy delivery (AAV9) raises translational safety and feasibility considerations
Future Directions: Identify small-molecule IRF7 modulators or downstream autophagy targets; develop biomarkers of IRF7 activity; evaluate efficacy in diverse infection models and human primary cells.
Sepsis contributes substantially to mortality rates worldwide, yet clinical trials that have focused on its underlying pathogenesis have failed to demonstrate benefits. Recently, enhancing self-defense has been regarded as an emerging therapeutic approach. Autophagy is a self-defense mechanism that protects septic mice, but its regulatory factor is still unknown. Moreover, the role of interferon regulatory factor 7 (IRF7) in sepsis has been debated. Here, we showed that Irf7 deficiency increased mo